Literature DB >> 32470215

Signals 1, 2 and B cell fate or: Where, when and for how long?

Jackson S Turner1, Zachary L Benet1, Irina L Grigorova1.   

Abstract

Diverse B cell responses are important for generating antibody-mediated protection against highly variable pathogens. While some antigens can trigger T-independent B cell proliferation and short-term antibody production, development of long-term humoral immunity requires T-dependent B cell responses. The "two-signal" model of B cell activation has long been invoked to explain alternate B cell recruitment into immune response to foreign antigens vs. induction of tolerance to self-antigens. However, a number of other factors appear to influence the fate of mature B cells responding to antigen in vivo. In this review, we will discuss how various spatiotemporal scenarios of antigen access into secondary lymphoid organs, antigen valency and cellular environment of antigen acquisition by B cells, duration of B cell access to antigen and the timing of T cell help may affect follicular B cell fate, including death, survival, anergy, and recruitment into T-dependent responses. We will also highlight unresolved questions related to B cell activation and tolerance in vivo that may have important implications for vaccine development and autoimmunity.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  B cell receptor signaling; T cell help; T-dependent B cell response; activation-induced cell death; tolerance

Year:  2020        PMID: 32470215     DOI: 10.1111/imr.12865

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  10 in total

1.  Diverging regulation of Bach2 protein and RNA expression determine cell fate in early B cell response.

Authors:  Qianwen Hu; Tingting Xu; Min Zhang; Heng Zhang; Yongbo Liu; Hua-Bing Li; Chiqi Chen; Junke Zheng; Zhen Zhang; Fubin Li; Nan Shen; Wenqian Zhang; Ari Melnick; Chuanxin Huang
Journal:  Cell Rep       Date:  2022-07-05       Impact factor: 9.995

2.  Multimericity Amplifies the Synergy of BCR and TLR4 for B Cell Activation and Antibody Class Switching.

Authors:  Egest J Pone; Jenny E Hernandez-Davies; Sharon Jan; Emily Silzel; Philip L Felgner; D Huw Davies
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

Review 3.  The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis.

Authors:  Kim-Alicia Palzer; Vanessa Bolduan; Rudolf Käfer; Hartmut Kleinert; Matthias Bros; Andrea Pautz
Journal:  Cells       Date:  2022-04-28       Impact factor: 7.666

Review 4.  Genome edited B cells: a new frontier in immune cell therapies.

Authors:  Geoffrey L Rogers; Paula M Cannon
Journal:  Mol Ther       Date:  2021-09-24       Impact factor: 11.454

5.  B and Th cell response to Ag in vivo: Implications for vaccine development and diseases.

Authors:  Richard B Kennedy; Irina Grigorova
Journal:  Immunol Rev       Date:  2020-07       Impact factor: 10.983

6.  The impact of the Th17:Treg axis on the IgA-Biome across the glycemic spectrum.

Authors:  Heather T Essigmann; Kristi L Hoffman; Joseph F Petrosino; Goo Jun; David Aguilar; Craig L Hanis; Herbert L DuPont; Eric L Brown
Journal:  PLoS One       Date:  2021-10-20       Impact factor: 3.240

Review 7.  Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia.

Authors:  Francesco Forconi; Stuart A Lanham; Giorgia Chiodin
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

8.  Differential Requirement of Vav Proteins for Btk-dependent and -Independent Signaling During B Cell Development.

Authors:  Annika C Betzler; Sebastian Kieser; Katja Fiedler; Simon Laban; Marie-Nicole Theodoraki; Patrick J Schuler; Thomas Wirth; Kerry Tedford; Klaus-Dieter Fischer; Thomas K Hoffmann; Cornelia Brunner
Journal:  Front Cell Dev Biol       Date:  2022-02-23

9.  Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19.

Authors:  Anna E Boldova; Julia D Korobkin; Yury D Nechipurenko; Anastasia N Sveshnikova
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

Review 10.  Exploring the pathways to chronic lymphocytic leukemia.

Authors:  Freda K Stevenson; Francesco Forconi; Thomas J Kipps
Journal:  Blood       Date:  2021-09-09       Impact factor: 25.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.